Deliver patient-specific reports for any NGS panel in minutes with on-demand, expert-curated content and professional interpretation services
Today’s health care industry is witnessing a paradigm shift that is driving a tighter integration of genomic analysis modalities in patient care decisions. From disease diagnostics and prognostics to carrier screening and clinical trial enrollment, physicians and oncologists are ordering a growing number of genetic tests for an expanding menu of applications.
QIAGEN Clinical Insights (QCI) offers expert-curated knowledge, software and services to support clinical NGS data analysis and interpretation for any indication, on your platform, in a fraction of the time.
Expanded carrier screening (ECS) panels can detect rare mutations across hundreds of genes, which require meticulous literature searches that increase turnaround time and decrease accuracy.
Join us for a free webinar on May 13 to learn how your genetic testing lab can scale your ECS workflow up to 80% using QCI Interpret, clinical decision support software integrated with the industry’s largest knowledge base.
Interested in offering precision medicine testing services in your lab?
Join us on May 20 for the Every Lab Summit. Specifically for small to mid-sized molecular diagnostic labs, this 2-hour virtual event will explore how your team can compete to offer comprehensive genomic profiling services for precision oncology with the same speed, expertise, and confidence of large hospital networks and university centers.
You’ll learn how your lab can analyze and interpret large NGS oncology panels faster. You’ll receive virtual demos of our clinical NGS software. You’ll be eligible for FREE software trials. Space limited.
QIAGEN Clinical Insight (QCI) is an evidence-based decision support software intended as an aid in the interpretation of variants observed in genomic sequencing data. The software evaluates genomic variants in the context of published biomedical literature, professional association guidelines, publicly available databases and annotations, drug labels, and clinical-trials. Based on this evaluation, the software proposes a classification to aid in the interpretation of observed variants. The software is NOT intended as a primary diagnostic tool by physicians or to be used as a substitute for professional healthcare advice. Each laboratory is responsible for ensuring compliance with applicable international, national, and local clinical laboratory regulations and other specific accreditations requirements.